Search Results - "Connell, L.C."

Toxicities of the anti-PD-1 and anti-PD-L1 immune checkpoint antibodies by Naidoo, J., Page, D.B., Li, B.T., Connell, L.C., Schindler, K., Lacouture, M.E., Postow, M.A., Wolchok, J.D.

“…Immune checkpoint antibodies that augment the programmed cell death protein 1 (PD-1)/PD-L1 pathway have demonstrated antitumor activity across multiple…”
Get full text

Corrections to “Toxicities of the anti-PD-1 and anti-PD-L1 immune checkpoint antibodies” by Naidoo, J., Page, D.B., Li, B.T., Connell, L.C., Schindler, K., Lacouture, M.E., Postow, M.A., Wolchok, J.D.

Get full text

1635 - Intensive Care as a Key Player in the Changing Paradigm of Modern Cancer Care: A Single Institution Experience by Connell, L.C., Othman, F., Marsh, B., Carney, D.N., McCaffrey, J.A., Gorman, P.O., Kelly, C.M.

“…Many metastatic cancers are now treated similar to other chronic diseases. Expanding treatment options, increasing age; co-morbid illness; and improving…”
Get full text

Intensive Care as a Key Player in the Changing Paradigm of Modern Cancer Care: A Single Institution Experience by Connell, L.C., Othman, F., Marsh, B., Carney, D.N., McCaffrey, J.A., Gorman, P.O., Kelly, C.M.

Get full text